Showing results (31-40 of 76) with videos related to
Sort By:
Pageof 8
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2011
Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutationsTommaso De Pas, Francesca Toffalorio, Michela Manzotti, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2015
Erlotinib efficacy in NSCLC patients with high polysomy of chromosome 7 and EGFR/KRas wild-type tumorsFrancesca Toffalorio, Filippo de Marinis, Fabio Conforti, et al.Oncotargets and Therapy|May 24, 2014
Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642EChiara Catania, Fabio Conforti, Gianluca Spitaleri, et al.Breast Cancer Research and Treatment|January 30, 2007
Fulvestrant in heavily pre-treated patients with advanced breast cancer: results from a single compassionate use programme centreChiara Catania, Gilda Ascione, Laura Adamoli, et al.Critical Reviews in Oncology/Hematology|February 28, 2012
Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trialsTommaso De Pas, Monica Giovannini, Maria Rescigno, et al.Seminars in Oncology|December 8, 2023
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysisLaura Pala, Tommaso De Pas, Erika Stucchi, et al.European Journal of Cancer (Oxford, England : 1990)|August 15, 2022
Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative groupGabriele Antonarelli, Chiara Corti, Paolo Andrea Zucali, et al.Journal of Cancer Research and Clinical Oncology|November 19, 2015
Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires--an Italian exploratory studyChiara Catania, Irene Feroce, Monica Barile, et al.JNCI Cancer Spectrum|December 21, 2020
EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical TrialsFabio Conforti, Laura Pala, Vincenzo Bagnardi, et al.Lung Cancer (Amsterdam, Netherlands)|January 11, 2023
High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network studyFabio Conforti, Laura Pala, Grazia Vivanet, et al.Pageof 8